Product Information
LANSOPRAZOLE DR 30 MG ODT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.2103 per EA under NDC 00093300993. Its NADAC has been published 418 times since Aug 22, 2018.
FDA first approved this application on Sep 21, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093300993
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA208784FDA Approved
9/21/2017
TE Code
AB
On Market Since
3/8/2018
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG ODT has been published 418 times since Aug 22, 2018, and over the history we have for it it has declined 79.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2103 per EA |
|---|---|
| All-time high | $11.2227 (Jun 12, 2019) |
| All-time low | $1.8384 (Apr 22, 2026) |
| 52-week high | $2.8016 |
| 52-week low | $1.8384 |
| Median price | $4.5822 |
| Average price | $5.3957 |
| Largest weekly change | +43.5% (Sep 22, 2021) |
| Weeks tracked | 418 |
| Tracking since | Aug 22, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG ODT, manufactured by Teva Pharmaceuticals USA Inc., is $2.2103 per EA (NDC 00093300993), effective Aug 19, 2026.
How has the price of LANSOPRAZOLE DR 30 MG ODT changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG ODT has declined 79.8%. It has been tracked across 418 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG ODT?
Since Aug 22, 2018, the NADAC for LANSOPRAZOLE DR 30 MG ODT has ranged from a low of $1.8384 (Apr 22, 2026) to a high of $11.2227 (Jun 12, 2019), with a median of $4.5822 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG ODT?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LANSOPRAZOLE DR 30 MG ODT in a comparable dosage form, but none are currently priced below it.
Who manufactures LANSOPRAZOLE DR 30 MG ODT?
LANSOPRAZOLE DR 30 MG ODT (NDC 00093300993) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.